Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Related Citations for PubMed (Select 23307265)

1.

Inhaled tiotropium to prevent postoperative cardiopulmonary complications in patients with newly diagnosed chronic obstructive pulmonary disease requiring lung cancer surgery.

Nojiri T, Inoue M, Yamamoto K, Maeda H, Takeuchi Y, Nakagiri T, Shintani Y, Minami M, Sawabata N, Okumura M.

Surg Today. 2014 Feb;44(2):285-90. doi: 10.1007/s00595-012-0481-5. Epub 2013 Jan 10.

PMID:
23307265
2.

Low-dose human atrial natriuretic peptide for the prevention of postoperative cardiopulmonary complications in chronic obstructive pulmonary disease patients undergoing lung cancer surgery.

Nojiri T, Inoue M, Maeda H, Takeuchi Y, Sawabata N, Shintani Y, Yamamoto K, Okumura M.

Eur J Cardiothorac Surg. 2013 Jul;44(1):98-103. doi: 10.1093/ejcts/ezs646. Epub 2012 Dec 14.

PMID:
23242980
3.
4.

Effects of inhaled tiotropium on left ventricular diastolic function in chronic obstructive pulmonary disease patients after pulmonary resection.

Nojiri T, Yamamoto K, Maeda H, Takeuchi Y, Funakoshi Y, Maekura R, Okumura M.

Ann Thorac Cardiovasc Surg. 2012;18(3):206-11.

5.

Preoperative use of inhaled tiotropium in lung cancer patients with untreated COPD.

Kobayashi S, Suzuki S, Niikawa H, Sugawara T, Yanai M.

Respirology. 2009 Jul;14(5):675-9. doi: 10.1111/j.1440-1843.2009.01543.x. Epub 2009 May 19.

PMID:
19476597
6.

Role of inhaled tiotropium on the perioperative outcomes of patients with lung cancer and chronic obstructive pulmonary disease.

Ueda K, Tanaka T, Hayashi M, Hamano K.

Thorac Cardiovasc Surg. 2010 Feb;58(1):38-42. doi: 10.1055/s-0029-1186269. Epub 2010 Jan 13.

PMID:
20072975
7.

[Successful lobectomy in 3 lung cancer cases with severe COPD after treatment with tiotropium bromide].

Matsuyama W, Suetsugu T, Kawabata T, Kubota S, Iwakawa J, Higashimoto I, Osame M, Arimura K.

Nihon Kokyuki Gakkai Zasshi. 2007 Feb;45(2):194-7. Japanese.

PMID:
17352180
8.

Effects of low-dose human atrial natriuretic peptide for preventing post-operative cardiopulmonary complications in elderly patients undergoing pulmonary resection for lung cancer.

Nojiri T, Inoue M, Yamamoto K, Maeda H, Takeuchi Y, Funakoshi Y, Okumura M.

Eur J Cardiothorac Surg. 2012 Jun;41(6):1330-4. doi: 10.1093/ejcts/ezr202. Epub 2012 Jan 18.

PMID:
22290883
9.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
10.

Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.

Welsh EJ, Cates CJ, Poole P.

Cochrane Database Syst Rev. 2013 May 31;5:CD007891. doi: 10.1002/14651858.CD007891.pub3. Review.

PMID:
23728670
11.

Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial.

Niewoehner DE, Rice K, Cote C, Paulson D, Cooper JA Jr, Korducki L, Cassino C, Kesten S.

Ann Intern Med. 2005 Sep 6;143(5):317-26.

PMID:
16144890
12.

Influence of chronic obstructive pulmonary disease on postoperative lung function and complications in patients undergoing operations for primary non-small cell lung cancer.

Subotic DR, Mandaric DV, Eminovic TM, Gajic MM, Mujovic NM, Atanasijadis ND, Dzeletovic PP, Andric LD, Bulajic BM, Dimitrijevic ID, Sobic DP.

J Thorac Cardiovasc Surg. 2007 Nov;134(5):1292-9.

PMID:
17976465
14.

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.

Casaburi R, Mahler DA, Jones PW, Wanner A, San PG, ZuWallack RL, Menjoge SS, Serby CW, Witek T Jr.

Eur Respir J. 2002 Feb;19(2):217-24.

15.

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.

Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA; INSPIRE Investigators.

Am J Respir Crit Care Med. 2008 Jan 1;177(1):19-26. Epub 2007 Oct 4.

PMID:
17916806
16.

Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.

Welsh EJ, Cates CJ, Poole P.

Cochrane Database Syst Rev. 2010 May 12;(5):CD007891. doi: 10.1002/14651858.CD007891.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;5:CD007891.

PMID:
20464758
17.

Lung deposition of radiolabeled tiotropium in healthy subjects and patients with chronic obstructive pulmonary disease.

Brand P, Meyer T, Weuthen T, Timmer W, Berkel E, Wallenstein G, Scheuch G.

J Clin Pharmacol. 2007 Oct;47(10):1335-41. Epub 2007 Jul 11.

PMID:
17625157
18.

Tiotropium reduces risk of exacerbations irrespective of previous use of inhaled anticholinergics in placebo-controlled clinical trials.

Cooper CB, Anzueto A, Decramer M, Celli B, Tashkin DP, Leimer I, Kesten S.

Int J Chron Obstruct Pulmon Dis. 2011;6:269-75. doi: 10.2147/COPD.S17864. Epub 2011 May 9.

19.
20.

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium.

Ann Intern Med. 2007 Apr 17;146(8):545-55. Epub 2007 Feb 19.

PMID:
17310045
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk